Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

New use for Uriach's rupatadine

Oct. 11, 1996

New strategy for reducing doxorubicin toxicity

Oct. 11, 1996

Kanebo reports antitumor agent with a novel mechanism of action

Oct. 11, 1996

MMP inhibitors from Otsuka

Oct. 11, 1996

Nippon Kayaku evaluates novel doxorubicin preparation

Oct. 11, 1996

Antitumor antibiotics from the Kitasato Institute

Oct. 11, 1996

FK-317, a new antitumor antibiotic from Fujisawa

Oct. 11, 1996

Cubist evaluating new class of antibacterial agents

Oct. 11, 1996

New family of marine natural products discovered

Oct. 11, 1996

Procter & Gamble focuses on multifunctional antibacterial agents

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...